Trillium Therapeutics Inc (TRIL)

17.75 +0.08  +0.45% NASDAQ Oct 20, 16:00 17.85 +0.10  +0.56% Pre-Market: 08:13 USD
View Full Chart
Price Chart
View All TRIL News

News

View All Events

Events

Date Type Description
11/16/2021 Earnings Results Q3 2021 Earnings Results
08/13/2021 Earnings Results Q2 2021 Earnings Results
06/08/2021 13:00 EST AGM 2020 Annual General Meeting
05/07/2021 Earnings Results Q1 2021 Earnings Results
03/18/2021 Earnings Results Q4 2020 Earnings Results
11/16/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.
  • URL: https://www.trilliumtherapeutics.com
  • Investor Relations URL: https://ir.trilliumtherapeutics.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 16, 2021
  • Last Earnings Release: Aug. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.